Therapeutic Treatment for Benign Prostatic Hyperplasia

  • ISBN 9781841846019
  • Author: Kirby, Roger S.
  • Publ Date: 2005-06-16
  • Edition:
  • Binding: Hardback

$347.83
Sale: $313.05
Save: 10% off
+ GST

Add to Cart:
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90 per cent of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - the "Textbook" "of Benign Prostatic Hyperplasia, 2nd edition" - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.
Whilst every effort is made to keep pricing information up-to-date, prices and availability are subject to change without notice. Where prices or other details have changed from those listed on the website we will contact the customer and only proceed with the order after receiving acceptance of the revised pricing.
Your IP Address is: 52.14.187.31
Copyright © 2025 Medical Books. Powered by Zen Cart